Abstract
Dyschromia can be distressing to patients and difficult to treat, whether it is related to skin-resurfacing procedures, surgery, hormonal changes, environmental exposure, or genetic predisposition. Stephen Mulholland, MD; Michael Kulick, MD; and Brooke R. Seckel, MD, address some frequently asked treatment questions posed by “Comparing Notes” editor Alan H. Gold, MD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
